申请人:E.R. Squibb & Sons, Inc.
公开号:EP0053902A1
公开(公告)日:1982-06-16
Esters of phosphinylalkanoyl prolines and phosphinylalkanoyl substituted prolines are inhibitors of angiotensin converting enzyme and are useful in the treatment of hypertension.
膦酰基烷酰基脯氨酸酯和膦酰基烷酰基取代的脯氨酸是血管紧张素转换酶的抑制剂,可用于治疗高血压。